CFM
ZBH icon

Catalyst Funds Management’s Zimmer Biomet ZBH Stock Holding History

Catalyst Funds Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,200
Closed -$232K – 605
2024
Q4 		$232K Buy
+2,200
New +$236K 0.06% 238
2024
Q3 		– Sell
-100
Closed -$10.9K – 1639
2024
Q2 		$10.9K Buy
+100
New +$11.8K ﹤0.01% 895

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Catalyst Funds Management's ZBH Position: Q1 2025 in Review

Catalyst Funds Management sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 2,200 shares — an estimated $232K sold.

Catalyst Funds Management first reported a position in ZBH in Q2 2024 and held it in 2 quarters. The position peaked at $232K in Q4 2024. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

  • Catalyst Funds Management reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
  • Catalyst Funds Management sold 2,200 Zimmer Biomet shares in Q1 2025, an estimated $232K.
  • Catalyst Funds Management first reported a position in Zimmer Biomet in Q2 2024 and held it in 2 quarters.
  • Catalyst Funds Management's Zimmer Biomet position peaked at $232K in Q4 2024.
  • 1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Catalyst Funds Management's 13F filing for Q1 2025, filed 14 May 2025.